Medical research suggests that for full-term newborns, venepuncture—the process of drawing blood directly from a vein using a needle—may be less painful than the traditional heel lance method. While heel lancing remains the standard practice in many hospitals worldwide for small-volume blood collection, evidence indicates that venepuncture often requires fewer repeat punctures to obtain a successful sample, thereby minimizing the total pain experienced by the infant.
…
Comparing Pain and Procedural Efficiency
The choice between venepuncture and heel lance often hinges on the volume of blood required and the clinical setting. Heel lance involves using an automatic device to create a small puncture, typically 1 mm to 2 mm deep, into the infant’s heel. Because this method is widely used for samples under 1 mL, it is often perceived as the default for routine screenings. However, the procedure requires the clinician to squeeze the infant’s heel to encourage blood flow, a step that can cause additional discomfort and stress for the baby.
In contrast, venepuncture involves a direct needle insertion into a vein. While this technique demands a higher level of clinical training to ensure success, it is frequently used when larger volumes of blood are needed. Recent data comparing these two methods, updated through July 2025, suggests that venepuncture offers a distinct advantage in both pain management and success rates. According to a systematic review of eight studies involving 826 full-term newborns, infants who underwent venepuncture probably experienced less pain than those who underwent heel lancing, particularly when no sweet-tasting solution was administered for pain relief. Furthermore, the analysis found that venepuncture probably reduced the need for more than one skin puncture compared to heel lance.
The Role of Pain Management in Neonatal Care
Managing pain in newborns is a critical component of neonatal medicine. Untreated pain is not merely a momentary distress; it can have lasting implications for a child’s physical growth and neurodevelopment. To mitigate this, clinicians often administer a sucrose-based, sweet-tasting solution to the infant shortly before the procedure. This intervention is widely recognized for its ability to provide temporary pain relief and comfort during minor medical interventions.
When sucrose is used, the comparison between venepuncture and heel lance becomes more complex. The research suggests venepuncture may cause less pain compared to heel lance even with sucrose, but researchers are uncertain about the effect of venepuncture compared to heel lance on the need for more than one skin puncture. This highlights a gap in existing clinical research, as the efficacy of these methods appears to vary depending on the use of pharmacological or non-pharmacological comfort measures.
Despite the findings, the medical community maintains a cautious stance due to the limitations of current studies. The confidence level in the available evidence ranges from moderate to very low. Several factors contribute to this assessment. Many of the studies included in recent reviews had small sample sizes, which can limit the generalizability of the results. Additionally, there were inconsistencies in how infants were assigned to study groups and how pain outcomes were recorded.
A significant challenge in these clinical trials is the “blinding” of the procedure. Because the person performing the blood draw and the individual assessing the baby’s response—such as facial expressions, crying duration, and heart rate fluctuations—are typically aware of which method is being used, there is a potential for observer bias. To establish a definitive “gold standard” for newborn blood sampling, the medical community requires larger, more rigorously designed randomized controlled trials that ensure objective, blinded assessment of infant distress.
Clinical Implications and Next Steps
For parents and healthcare providers, the current evidence suggests that while venepuncture may be a superior option for minimizing pain and reducing the number of required punctures, the decision should be balanced against the expertise of the staff and the specific clinical needs of the infant. The goal remains consistent across all neonatal units: to provide necessary diagnostic care while prioritizing the comfort and development of the newborn.
As of mid-2025, the medical community continues to look for standardized guidelines that can reconcile these findings. Future research is expected to focus on larger cohorts to clarify the role of sucrose and the specific conditions under which venepuncture is most effective. For those seeking the most recent updates on neonatal care protocols and evidence-based practices, official guidance from national pediatric associations and international health organizations remains the most reliable source for clinical decision-making.
Have you had experiences with neonatal blood draws, or are you a healthcare professional interested in these findings? Join the discussion in the comments section below to share your perspective on how we can improve the standard of care for our smallest patients.
